Task D8: Nonclinical Services for Interventional Agents against SARS-CoV-2
$1,883,524N01FY2022AINIH
Iit Research Institute, Chicago IL
Investigators
Abstract
The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.
View original record on NIH RePORTER →